Coexpression of GSK-3β Corrects Phenotypic Aberrations of Dorsal Root Ganglion Cells, Cultured from Adult Transgenic Mice Overexpressing Human Protein tau
- 28 February 2002
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 9 (1), 38-48
- https://doi.org/10.1006/nbdi.2001.0454
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitroCell and tissue research, 2000
- The function of the microtubule‐associated protein tau is variably modulated by graded changes in glycogen synthase kinase‐3β activityFEBS Letters, 1999
- Motor and cargo interactionsEuropean Journal of Biochemistry, 1999
- τ is phosphorylated by GSK‐3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A‐kinaseFEBS Letters, 1998
- Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenesNeuroReport, 1997
- Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neuronsFEBS Letters, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Domains of tau Protein and Interactions with MicrotubulesBiochemistry, 1994
- The fast axonal transport in hippocampal neurones is acutely enhanced by db-cAMPNeuroReport, 1993